12:00 AM
Sep 27, 1999
 |  BC Week In Review  |  Clinical News  |  Regulatory

Derivatives of Arglabin inhibitor of farnesyl transferase regulatory update

NLAB subsidiary Paracure Inc. received notice of allowance for a U.S. patent covering...

Read the full 41 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >